Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02237599
Other study ID # 104826
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 2014
Est. completion date December 2018

Study information

Verified date March 2019
Source Lawson Health Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study hypothesizes that an automated device using small electronic impulses can detect nerve impairment in unconscious patients.


Description:

Application of SSEP probes to bilateral ulnar and popliteal nerve areas with sensors at (1) bilateral brachial plexus (clavicles), (2) Erb's point (posterior C8 cervical spine) and (3) on forehead will permit microvolt current to to be detected and analyzed against a proprietary algorithm. Neuropraxia will be detected based on abnormalities developing in received SSEP signals.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

- elective surgery

Exclusion Criteria:

- neuromuscular disease stroke

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada University Hospital London Ontario

Sponsors (1)

Lead Sponsor Collaborator
Lawson Health Research Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neuropraxia Correlation between postoperative neuropraxia and intraoperative alert of impaired neural transmission detected via EPAD postoperative
See also
  Status Clinical Trial Phase
Completed NCT02532582 - Assessment of Patient Positioning